A detailed history of Beacon Pointe Advisors, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 16,457 shares of PEN stock, worth $3.91 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,457
Previous 16,440 0.1%
Holding current value
$3.91 Million
Previous $2.96 Million 8.01%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.64 - $210.12 $2,781 - $3,572
17 Added 0.1%
16,457 $3.2 Million
Q2 2024

Aug 12, 2024

SELL
$172.27 - $223.95 $516 - $671
-3 Reduced 0.02%
16,440 $2.96 Million
Q1 2024

May 14, 2024

SELL
$220.09 - $273.15 $1.56 Million - $1.94 Million
-7,090 Reduced 30.13%
16,443 $3.67 Million
Q4 2023

Feb 08, 2024

BUY
$181.44 - $260.22 $4.27 Million - $6.12 Million
23,533 New
23,533 $5.92 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.